Foresee Pharmaceuticals Co., Ltd. (TPEX:6576)
Taiwan
· Delayed Price · Currency is TWD 86.00
+0.20 (0.23%)
Feb 21, 2025, 1:30 PM CST
Foresee Pharmaceuticals Revenue
Foresee Pharmaceuticals had revenue of 80.10M TWD in the quarter ending September 30, 2024, with 31.92% growth. This brings the company's revenue in the last twelve months to 346.56M, up 154.13% year-over-year. In the year 2023, Foresee Pharmaceuticals had annual revenue of 195.04M, down -35.31%.
Revenue (ttm)
346.56M
Revenue Growth
+154.13%
P/S Ratio
33.78
Revenue / Employee
n/a
Employees
n/a
Market Cap
13.31B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 195.04M | -106.47M | -35.31% |
| Dec 31, 2022 | 301.51M | 75.48M | 33.39% |
| Dec 31, 2021 | 226.03M | -4.41M | -1.91% |
| Dec 31, 2020 | 230.44M | 155.24M | 206.44% |
| Dec 31, 2019 | 75.20M | 49.16M | 188.82% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 8.32B |
| Caliway Biopharmaceuticals | 44.43M |
| Bora Pharmaceuticals Co., LTD. | 16.71B |
| Lotus Pharmaceutical | 17.59B |
| Lumosa Therapeutics | 37.82M |
| Oneness Biotech | 112.20M |
| Polaris Group | 75.65M |
| Pegavision | 7.06B |